Fig. 3From: Prognostic value of lymphocyte-to-monocyte ratio in ovarian cancer: a meta-analysisPooled hazard ratio (HR) of lymphocyte-to-monocyte (LMR) for progression-free survival (PFS) in patients with ovarian cancerBack to article page